Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00517634 · ClinicalTrials.gov registry record · Phase 4
Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT00517634 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 23 participants.
The verdict
NCT00517634, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
The aim of the present study is to investigate whether the effects of salmeterol in combination with fluticasone propionate on blood markers of airway inflammation are maintained after chronic dosing and whether the effect is influenced by the time of allergen challenge relative to the time of dosing.
Interventions
- DRUG Placebo
- DRUG FP
- DRUG SFC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00517634
The ClinicalTrials.gov registry entry for NCT00517634 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00517634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00517634 about?
NCT00517634 is a clinical study titled "Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects". The aim of the present study is to investigate whether the effects of salmeterol in combination with fluticasone propionate on blood markers of airway inflammation are maintained after chronic dosing and whether the effect is influenced by the time of allergen challenge relative to the time of dosin...
What is the current status of trial NCT00517634?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2007-08. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00517634?
The interventions under investigation include: Placebo (DRUG), FP (DRUG), SFC (DRUG).
Who is sponsoring clinical trial NCT00517634?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.